Adult Immunization Resources

Estimated Influenza Illnesses, Medical Visits, Hospitalizations, and Deaths Averted by Vaccination in the United States:

https://www.cdc.gov/flu/about/disease/2015-16.htm

Behavioral Risk Factor Surveillance System (BRFFS) Prevalence Data and Analysis 2016: https://www.cdc.gov/brfss/brfssprevalence/

Standards for Adult Immunization Practice 2013: https://www.cdc.gov/vaccines/hcp/adults/for-practice/standards/index.html

2018 CDC Adult Immunization Schedule by Vaccine and Age Group: https://www.cdc.gov/vaccines/schedules/hcp/imz/adult.html

2018 CDC Adult Immunization Schedule by Medical and Other Indications: https://www.cdc.gov/vaccines/schedules/hcp/imz/adult-conditions.html

Healthcare Personnel Vaccination Recommendations: http://www.immunize.org/catg.d/p2017.pdf

Epidemiology and Prevention of Vaccine Preventable Diseases-Chapter 4 Vaccine Safety: https://www.cdc.gov/vaccines/pubs/pinkbook/safety.html

Screening Checklist for Contraindications to Vaccines for Adults: http://www.immunize.org/catg.d/p4065.pdf

Pertussis Frequently Asked Questions: https://www.cdc.gov/pertussis/about/faqs.html

CDC Pertussis (Whooping Cough) Complications: https://www.cdc.gov/pertussis/about/complications.html

Vaccine Preventable Diseases in Michigan-Annual Summaries: http://www.michigan.gov/mdhhs/0,5885,7-339-73971_4911_4914_6385-47024--,00.html

Vaccination Coverage Among Adults in the United States, National Health Interview Survey, 2016: https://www.cdc.gov/vaccines/imz-managers/coverage/adultvaxview/NHIS-2016.html#tetanus

Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis (Tdap) Vaccine in Pregnant Women: https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6207a4.htm

Vaccination Coverage Among Adults in the United States National Health Interview Survey, 2016: https://www.cdc.gov/vaccines/imz-managers/coverage/adultvaxview/pubs-resources/NHIS-2016.html

CDC Vaccinating Pregnant Patients: https://www.cdc.gov/pertussis/pregnant/hcp/pregnant-patients.html

October 2016 ACIP Slides: https://www.cdc.gov/vaccines/acip/meetings/downloads/slides-2016-10/pertussis-02-liang.pdf

Tetanus Prophylaxis Guidelines: http://www.michigan.gov/documents/mdhhs/Tetanus_Prophy_All_Ages_524279_7.pdf

Basic Information about HPV and Cancer: https://www.cdc.gov/cancer/hpv/basic_info/

CDC Basic Genital HPV Infection-Fact Sheet: https://www.cdc.gov/std/hpv/stdfact-hpv.htm

HPV Associated Cancer Statistics: https://www.cdc.gov/cancer/hpv/statistics/index.htm

United States Cancer Statistics Data Brief No. 1 December 2017: https://www.cdc.gov/cancer/hpv/pdf/USCS-DataBrief-No1-December2017-508.pdf

Use of a 2-Dose Schedule for Human Papillomavirus Vaccination-Updated Recommendations of the Advisory Committee on Immunization Practices, Dec 16, 2016: https://www.cdc.gov/mmwr/volumes/65/wr/mm6549a5.htm

Prevalence of HPV Among Females After Vaccine Introduction-National Health and Nutrition Examination Survey, United States, 2003-2014; The Journal of Infectious Diseases, September 1, 2017/Vol. 216(5) Pages 594-603: https://www.ncbi.nlm.nih.gov/pubmed/28931217

Use of 9-Valent Human Papillomavirus (HPV) Vaccine MMWR March 27, 2015: https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6411a3.htm

Prevention and Control of Meningococcal Disease: Recommendations of the Advisory Committee on Immunization Practices (ACIP), Recommendations and Reports March 22, 2013: https://www.cdc.gov/mmwr/preview/mmwrhtml/rr6202a1.htm

Epidemiology and Prevention of Vaccine Preventable Diseases, 13^th Edition, 2015: https://www.cdc.gov/vaccines/pubs/pinkbook/index.html

Recommendations for Use of Meningococcal Conjugate Vaccines in HIV Infected Persons MMWR 2016: https://www.cdc.gov/mmwr/volumes/65/wr/mm6543a3.htm

MDHHS Quarterly County Report Cards: http://www.michigan.gov/mdhhs/0,5885,7-339-73971_4911_4914_68361-321114--,00.html

Meningococcal Vaccine Recommendations by Age and Risk Factor for Serogroups A, C, W, Y Protection (IAC Handout): http://www.immunize.org/va/va47_meningococcal_recs.pdf

High Risk for Invasive Meningococcal Disease Among Patients Receiving Eculizumab (Soliris) Despite Receipt of Meningococcal Vaccine July 14, 2017: https://www.cdc.gov/mmwr/volumes/66/wr/mm6627e1.htm

General Best Practice Guidelines for Immunizations: https://www.cdc.gov/vaccines/hcp/acip-recs/general-recs/index.html

2018 Children and Adolescent Immunization Schedule: https://www.cdc.gov/vaccines/schedules/hcp/child-adolescent.html

Use of Serogroup B Meningococcal Vaccines in Persons Aged 10 Years and older: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6422a3.htm

Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults > 65 Years: https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6337a4.htm

Immunization Action Coalition Pneumococcal Vaccination Recommendations for Children and Adults by Age and/or Risk Factor Handout: http://www.immunize.org/catg.d/p2019.pdf

Intervals Between PCV13 and PPSV23 Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP), MMWR, September 4, 2015: https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6434a4.htm

Recommendations of the Advisory Committee on Immunization Practices for Use of a Hepatitis B Vaccine with a Novel Adjuvant: www.cdc.gov/mmwr/volumes/67/wr/pdfs/mm6715a5-H.pdf

Update: Prevention of Hepatitis A after Exposure to Hepatitis A Virus and in International Travelers, Recommendations of the ACIP, MMWR October 19, 2007: https://www.cdc.gov/mmwr/preview/mmwrhtml/mm5641a3.htm

MDHHS-Hepatitis A Southeast Michigan Outbreak: www.Michigan.gov/hepatitisaoutbreak

Prevention of Hepatitis A Through Active or Passive Immunization, Recommendations of the ACIP, May 19, 2006: https://www.cdc.gov/mmwr/preview/mmwrhtml/rr5507a1.htm

Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP), United States, 2017-18 MMWR August 25, 2017: https://www.cdc.gov/mmwr/volumes/66/rr/rr6602a1.htm

ACIP Recommendations for the Use of Quadrivalent Live Attenuated Influenza Vaccine (LAIV4)-United States, 2018-19 Influenza Season: https://www.cdc.gov/mmwr/volumes/67/wr/mm6722a5.htm

Seasonal Influenza Vaccines Presentation Chart 2017-2018: http://www.michigan.gov/documents/mdhhs/Flu_Presentation_Chart_17-18_Final_599285_7.pdf

2017-18 Flu Vaccine Screening for Persons who Report Egg Allergy: http://www.michigan.gov/documents/mdhhs/Egg_Screening_17-18_Final_599294_7.pdf

Pregnant Women and Flu Vaccination, Internet Panel Survey, United States, November 2017: https://www.cdc.gov/flu/fluvaxview/pregnant-women-nov2017.htm

Interim Estimates of 2017-18 Seasonal Influenza Vaccine Effectiveness-United States, February 2018: https://www.cdc.gov/mmwr/volumes/67/wr/pdfs/mm6706-H.pdf

Influenza Antiviral Medications: Summary for Clinicians: https://www.cdc.gov/flu/professionals/antivirals/summary-clinicians.htm

MDHHS Influenza Website: www.michigan.gov/flu

World Health Organization 2018-2019 Influenza Vaccine composition: http://www.who.int/influenza/vaccines/virus/recommendations/2018_19_north/en/

Frequently Asked Flu Questions 2017-2018 Influenza Season: https://www.cdc.gov/flu/about/season/flu-season-2017-2018.htm

Weekly U.S. Influenza Surveillance Report: https://www.cdc.gov/flu/weekly/

Alliance in Michigan Immunization Provider Toolkit: www.aimtoolkit.org

Measles Data: https://www.cdc.gov/measles/cases-outbreaks.html

Mumps Data: https://www.cdc.gov/mmwr/mmwr_nd/index.html

MDHHS Press Release-Measles Case Identified in Michigan; Health Officials Urge Protection Through Vaccination: https://content.govdelivery.com/attachments/MIDHHS/2018/03/14/file_attachments/973457/Measles%2B2018%2BNR.pdf

Recommendation of the Advisory Committee on Immunization Practices for Use of a Third Dose of Mumps Virus-Containing Vaccine in Persons at Increased Risk for Mumps During an Outbreak MMWR January 12, 2018 Vol. 67(1): https://www.cdc.gov/mmwr/volumes/67/wr/pdfs/mm6701a7-H.pdf

Prevention of Varicella, Recommendations of the ACIP, MMWR June 22, 2007: https://www.cdc.gov/mmwr/preview/mmwrhtml/rr5604a1.htm

Summary of Vaccine Preventable Diseases (VPD’s) Reported to MDHHS in 2016: http://www.michigan.gov/documents/mdhhs/VPD_Summary_2016_604865_7.pdf

CDC-Considerations for the Use of Herpes Zoster Vaccines: https://www2.cdc.gov/vaccines/ed/ciinc/archives/17/downloads/11_8_17/Zoster_CIINC_Dooling_20171106.pdf

Recommendations of the Advisory Committee on Immunization Practices for Use of Herpes Zoster Vaccines January 26, 2018 Vol. 67(3); 103-108: https://www.cdc.gov/mmwr/volumes/67/wr/mm6703a5.htm

Epidemiology and Prevention of Vaccine Preventable Diseases 13^th Edition Chapter 22: https://www.cdc.gov/vaccines/pubs/pinkbook/index.html

Shingrix Package Insert: https://www.gsksource.com/pharma/content/dam/GlaxoSmithKline/US/en/Prescribing_Information/Shingrix/pdf/SHINGRIX.PDF

Michigan Care Improvement Registry: www.mcir.org

Centers for Disease Control and Prevention (CDC) Vaccine Storage and Handling Toolkit June 2016: https://www.cdc.gov/vaccines/hcp/admin/storage/toolkit/index.html

Michigan Department of Health and Human Services Immunization Division: www.michigan.gov/immunize

Vaccine Adverse Event Reporting System: https://vaers.hhs.gov/index

Immunization Action Coalition: www.immunize.org